Clinical Trial Update: Trial to Assess Chelation Therapy 2 [Phase 3]

View source ↗

Summary

Phase 3 trial results for Chelation Therapy 2 have been posted, evaluating disodium EDTA-based chelation in patients with diabetes and prior myocardial infarcti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Myocardial Infarction

Drugs mentioned

• Chelation therapy with disodium EDTA (ethylenediaminetetraacetic acid (EDTA))

Snippet

Sponsor: Mt. Sinai Medical Center, Miami | Conditions: Diabetes, Myocardial Infarction | Phase 3 | Status: COMPLETED | Results posted: 2024-10-01